FIELD: medicine.
SUBSTANCE: composition of 5,10,15,20-tetrakis(N-methyl-3'-pyridyl)chlorine and 5,10,15,20-tetrakis(N-methyl-3'-pyridyl)bacteriochlorine is administered into a tumour tissue as a photosensitiser in an amount of 0.5-10mg per 1g of tumour tissue depending on a degree of tumour differentiation. The laser exposure starts 20-40 minutes later at wave length 760-762 nm. The cytological examination follows 6-7 days later, and if observing signs of persistent tumour growth, the presented therapeutic session is repeated.
EFFECT: gradual depression of the malignant tumour tissue up to the complete elimination of its cell and structural abnormalities, lower rate of metastasis or progression prevention that makes it possible to avoid surgical intervention in some cases.
4 cl, 3 dwg, 3 ex
Title | Year | Author | Number |
---|---|---|---|
PHOTOSENSIBILISER AND METHOD OF OBTAINING THEREOF | 2013 |
|
RU2535097C1 |
PHOTOSENSITISERS FOR PHOTODYNAMIC THERAPY | 2012 |
|
RU2476218C1 |
PHOTOSENSITISER FOR PHOTODYNAMIC THERAPY | 2012 |
|
RU2479585C1 |
METHOD OF TREATMENT OF RHINOPHYMA IN COMBINATION WITH BASAL CELL CANCER OF NOSE TIP CT1N0M0 I ST | 2023 |
|
RU2802998C1 |
METHOD FOR PRODUCING CHLORINES AND PHARMACEUTICAL APPLICATIONS THEREOF | 2009 |
|
RU2513483C2 |
METHOD FOR PHOTODYNAMIC THERAPY OF MALIGNANT TUMOURS | 2016 |
|
RU2617090C1 |
METHOD OF INTRAOPERATIVE PHOTODYNAMIC THERAPY IN COMBINED TREATMENT OF LOCALLY ADVANCED SOFT TISSUE SARCOMAS | 2020 |
|
RU2737704C2 |
METHOD OF TREATING LOCALLY ADVANCED ONCOLOGICAL DISEASES IN EXPERIMENT | 2010 |
|
RU2446842C2 |
METHOD OF REHABILITATION SELECTIVE CHRONOPHOTOTHERAPY | 2007 |
|
RU2341307C1 |
METHOD OF TREATING BASAL CELL SKIN CANCER | 2018 |
|
RU2701096C1 |
Authors
Dates
2015-01-10—Published
2013-07-12—Filed